Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform - Communications Medicine Costello et al. assess the impact of ursodeoxycholic acid (UDCA) treatment on COVID-19-related outcomes among people with chronic primary biliary cirrhosis and primary sclerosing cholangitis. Using a ...

🚨 Publication alert 🚨

Ursodeoxycholic acid and severe COVID-19 outcomes in a cohort study using the OpenSAFELY platform

Paper here: doi.org/10.1038/s438...

(1/3) @darthctr.bsky.social @annaschultze.bsky.social @bengoldacre.bsky.social @lshtm.bsky.social @bennettoxford.bsky.social

Hello, world.